$2.13
-0.11 (-4.91%)
RXi Pharmaceuticals Corp. (RXII)
CAPS Rating:
Recs
0
RNAI continues to be one of the hottest fields in biotech and partnerships are likely to form for RXII
Recs
RNAI continues to be one of the hottest fields in biotech and partnerships are likely to form for RXII
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 1 of 1